ShunZhi Wang
Dados Biográficos
| ID | 8915643 |
|---|---|
| NOME | ShunZhi Wang |
| PRENOMES | ShunZhi |
| SOBRENOME | Wang |
| ASSINATURA | WANG S |
| AFILIAÇÕES | Ministry of Education - Singapore |
| ORCID | 0000-0001-5033-7478 |
| VERIFICADO | Sim |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAÇÕES | 0 |
| OBRAS COMO AUTOR | 1 |
| OBRAS COMO EDITOR | 0 |
| PRIMEIRO ANO DE PUBLICAÇÃO | 2026 |
| ANO MAIS RECENTE DE PUBLICAÇÃO | 2026 |
| ÍNDICE H | 0 |
Dabupi decoction mitigates fluorouracil-induced intestinal mucositis via farnesoid X receptor activation and dihydropyrimidine dehydrogenase upregulation
ETHNOPHARMACOLOGICAL RELEVANCE: 5-Fluorouracil (5-FU) is a widely utilized antimetabolite in colorectal cancer chemotherapy, primarily exerting its cytotoxic effects by irreversibly inhibiting thymidylate synthase (TS). This inhibition leads to a reduction in deoxythymidine monophosphate (dTMP), which disrupts DNA synthesis and repair. A major challenge in 5-FU treatment is the dose-limiting toxicity of chemotherapeutic-induced intestinal mucosit…
Sem obras proeminentes nesta página.
Dabupi decoction mitigates fluorouracil-induced intestinal mucositis via farnesoid X receptor activation and dihydropyrimidine dehydrogenase upregulation
ETHNOPHARMACOLOGICAL RELEVANCE: 5-Fluorouracil (5-FU) is a widely utilized antimetabolite in colorectal cancer chemotherapy, primarily exerting its cytotoxic effects by irreversibly inhibiting thymidylate synthase (TS). This inhibition leads to a reduction in deoxythymidine monophosphate (dTMP), which disrupts DNA synthesis and repair. A major challenge in 5-FU treatment is the dose-limiting toxicity of chemotherapeutic-induced intestinal mucosit…
Bile acid (1 obra) · Colorectal Cancer Treatments and Studies (1 obra) · Dihydropyrimidine dehydrogenase (1 obra) · Downregulation and upregulation (1 obra) · Effects of Radiation Exposure (1 obra) · Enzyme (1 obra) · Farnesoid X receptor (1 obra) · Mucositis (1 obra) · Oral health in cancer treatment (1 obra) · Thymidylate synthase (1 obra)